These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 29368409)

  • 1. Transgenic marmosets mimic Parkinson's symptoms.
    Normile D
    Science; 2024 Mar; 383(6690):1402. PubMed ID: 38547276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and developmental toxicity of the hallucinogenic plant-based beverage ayahuasca in rats.
    da Motta LG; de Morais JA; Tavares ACAM; Vianna LMS; Mortari MR; Amorim RFB; Carvalho RR; Paumgartten FJR; Pic-Taylor A; Caldas ED
    Reprod Toxicol; 2018 Apr; 77():143-153. PubMed ID: 29522798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment of glial cell-derived neurotrophic factor and geranylgeranylacetone ameliorates brain injury in Parkinson's disease by its anti-apoptotic and anti-oxidative property.
    Yue P; Gao L; Wang X; Ding X; Teng J
    J Cell Biochem; 2018 Jul; 119(7):5491-5502. PubMed ID: 29377238
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Djamshidian A; Bernschneider-Reif S; Poewe W; Lees AJ
    Mov Disord Clin Pract; 2016; 3(1):19-26. PubMed ID: 30713897
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
    Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC
    J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
    Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedside to bench: the outlook for psychedelic research.
    Acero VP; Cribas ES; Browne KD; Rivellini O; Burrell JC; O'Donnell JC; Das S; Cullen DK
    Front Pharmacol; 2023; 14():1240295. PubMed ID: 37869749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
    Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancient medicinal plants of South America.
    VanPool C
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11087-11089. PubMed ID: 31113878
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
    Lincoln L; Fisher R; Jackson MJ; Jenner P; Neumeyer J; Sromek AW; Lees AJ; Rose S
    Mov Disord; 2016 Sep; 31(9):1381-8. PubMed ID: 27133947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease.
    Fisher R; Lincoln L; Jackson MJ; Abbate V; Jenner P; Hider R; Lees A; Rose S
    Phytother Res; 2018 Apr; 32(4):678-687. PubMed ID: 29368409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets.
    Pearce RK; Smith LA; Jackson MJ; Banerji T; Scheel-Krüger J; Jenner P
    Mov Disord; 2002 Sep; 17(5):877-86. PubMed ID: 12360536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparkinsonian Effects of a Metabotropic Glutamate Receptor 4 Agonist in MPTP-Treated Marmosets.
    Mann E; Jackson M; Lincoln L; Fisher R; Rose S; Duty S
    J Parkinsons Dis; 2020; 10(3):959-967. PubMed ID: 32250315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).
    Maratos EC; Jackson MJ; Pearce RK; Jenner P
    Mov Disord; 2001 Jul; 16(4):631-41. PubMed ID: 11481686
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.